Company / Accounts Receivable
MANNKIND CORP Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$38.4M
FY2025
5-year range
$4.7M / $38.4M
FY2021-FY2025
Trend
+225.0%
vs FY2024
Sector context
#75 of 115
Health Care
What the data says
Accounts Receivable changed +225% YoY in FY2025, a notable deviation from the 9-year average annual change of +148%.
Based on SEC 10-K filings.
$38M in FY2025 with a 5-year CAGR of +55.5%.
Improved from $15M to $38M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +31.7%
- 5-Year CAGR
- +55.5%
- 10-Year CAGR
- -
Sector benchmark
#75 of 115 in Health CareTop 65% of 115This company $38.4M Sector average $1.1B
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +55.5%, indicating consistent growth.
- In FY2025, accounts receivable increased 225.0% year-over-year.
- Ranks #75 out of 115 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.4M | +225.0% |
| FY2024 | $11.8M | -20.8% |
| FY2023 | $14.9M | -11.3% |
| FY2022 | $16.8M | +254.5% |
| FY2021 | $4.7M | +12.4% |
| FY2020 | $4.2M | +20.1% |
| FY2019 | $3.5M | -12.5% |
| FY2018 | $4.0M | +44.0% |
| FY2017 | $2.8M | +823.5% |
| FY2016 | $302.0K | +1213.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026